PRAX

Praxis Precision Medicines, Inc.

43.49 USD
-0.59 (-1.34%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Praxis Precision Medicines, Inc. stock is down -23.51% since 30 days ago. The next earnings date is Aug 7, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 May’s closed higher than April. In the last 10 Unusual Options Trades, there were 10 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
16 May 14:22 19 Jul, 2024 45.00 PUT 110 0
16 May 14:22 19 Jul, 2024 45.00 PUT 34 0
16 May 14:22 19 Jul, 2024 45.00 PUT 34 0
17 May 13:51 19 Jul, 2024 45.00 PUT 73 320
21 May 14:24 19 Jul, 2024 45.00 PUT 98 401
21 May 17:31 19 Jul, 2024 45.00 PUT 37 401
21 May 17:31 19 Jul, 2024 45.00 PUT 75 401
21 May 17:31 19 Jul, 2024 45.00 PUT 75 401
21 May 17:31 19 Jul, 2024 45.00 PUT 75 401
21 May 17:33 19 Jul, 2024 45.00 PUT 100 401

About Praxis Precision Medicines, Inc.

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression.

  • Truist Securities
    Thu May 16, 13:21
    buy
    confirm
  • HC Wainwright & Co.
    Tue May 14, 07:44
    buy
    confirm
  • Baird
    Wed May 1, 05:23
    buy
    initial